Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors von KRÖGER, N, RENGES, H, SONNENBERG, S, KRÜGER, W, GUTENSOHN, K, DIELSCHNEIDER, T, CORTES-DERICKS, L, ZANDER, A. R

Volltext

Tolerance of granulocyte donors towards granulocyte colony‐stimulating factor stimulation and of patients towards granulocyte transfusions: results of a multicentre study von Bux, J., Cassens, U., Dielschneider, T., Duchscherer, M., Edel, E., Eichler, H., Haas, C., Moog, R., Peschke, H., Peters, C., Ryzenkov, I., Schlenke, P., Ullrich, H., Wiesneth, M.

Volltext

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors von Kröger, N, Renges, H, Sonnenberg, S, Krüger, W, Gutensohn, K, Dielschneider, T, Cortes-Dericks, L, Zander, A R

Volltext

Stem cell mobilisation with 16 mu g/kg vs 10 mu g/kg of G-CSF for allogeneic transplantation in healthy donors von Kroeger, N, Renges, H, Sonnenberg, S, Krueger, W, Gutensohn, K, Dielschneider, T, Cortes-Dericks, L, Zander, A R

Volltext

Stem cell mobilisation with 16 ]mu]g/kg vs10 ]mu]g/kg of G-CSF for allogeneic transplantation in healthy donors von Kroger, N, Renges, H, Sonnenberg, S, Kruger, W, Gutensohn, K, Dielschneider, T, Cortes-Dericks, L, Zander, A R

Volltext

Stem cell mobilisation with 16 [mu]g/kg vs 10 [mu]g/kg of G-CSF for allogeneic transplantation in healthy donors von Kröger, N, Renges, H, Sonnenberg, S, Krüger, W, Gutensohn, K, Dielschneider, T, Cortes-Dericks, L, Zander, A R

Volltext

Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors: Progenitor Cell Mobilisation von Kröger, N, Renges, H, Sonnenberg, S, Krüger, W, Gutensohn, K, Dielschneider, T, Cortes-Dericks, L, Zander, AR

Volltext

He 3 (e,d)e'p isochromats and angular distribution measurements von Skopik, D. M., Asai, J., Beck, D. H., Dielschneider, T. P., Pywell, R. E., Retzlaff, G. A.

Volltext

Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells von Ma, Shumei, Dielschneider, Rebecca F, Henson, Elizabeth S, Xiao, Wenyan, Choquette, Tricia R, Blankstein, Anna R, Chen, Yongqiang, Gibson, Spencer B

Volltext

Vaccine Hesitancy: Christian Reasons and Responses von Dielschneider, Rebecca

Volltext

Lysosomes as Oxidative Targets for Cancer Therapy von Dielschneider, Rebecca F., Gibson, Spencer, Henson, Elizabeth S.

Volltext

Practical Considerations in Vaccine Conversations von Dielschneider, Rebecca

Volltext

Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism von Dielschneider, R F, Eisenstat, H, Mi, S, Curtis, J M, Xiao, W, Johnston, J B, Gibson, S B

Volltext

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms von Gujar, S A, Clements, D, Dielschneider, R, Helson, E, Marcato, P, Lee, P W K

Volltext

An LC/MS/MS method for the simultaneous determination of individual sphingolipid species in B cells von Mi, Si, Zhao, Yuan-Yuan, Dielschneider, Rebecca F., Gibson, Spencer B., Curtis, Jonathan M.

Volltext

Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells von Das, Subhadip, Dielschneider, Rebecca, Chanas-LaRue, Aaron, Johnston, James B., Gibson, Spencer B.

Volltext

Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation von Gujar, Shashi, Dielschneider, Rebecca, Clements, Derek, Helson, Erin, Shmulevitz, Maya, Marcato, Paola, Pan, Da, Pan, Lu-zhe, Ahn, Dae-Gyun, Alawadhi, Abdulaziz, Lee, Patrick WK

Volltext

Abstract 5423: ZAP70 alters metabolism in chronic lymphocytic leukemic cells von Das, Subhadip, Dielschneider, RF, Henson, Elizabeth S., Gibson, Spencer B.

Volltext

Lysosome Membrane Permeabilization Causes Cell Death in Primary Chronic Lymphocytic Leukemia Cells von Dielschneider, Rebecca, Eisenstat, Hannah, Johnston, James B., Gibson, Spencer B

Volltext

Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling von Dielschneider, R F, Xiao, W, Yoon, J-Y, Noh, E, Banerji, V, Li, H, Marshall, A J, Johnston, J B, Gibson, S B

Volltext